| Symbol | ULGX |
|---|---|
| Name | UROLOGIX, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 55447 United States MN 14405 21st Avenue North |
| Telephone | (763) 475-1400 |
| Fax | — |
| — | |
| Website | http://www.urologix.com |
| Incorporation | US |
| Incorporated On | 1991 |
| Employees | — |
| Fiscal Year | 6/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Baker Tilly US, LLP; |
| Audit Status | NOT AVAILABLE |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0000882873 |
| Description | Urologix, Inc., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). Urologix Cooled ThermoTherapy produces targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva RF Therapy System delivers radio frequency energy directly into the prostate destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH symptoms. Both of these therapies provide safe, effective and lasting relief of the symptoms and obstruction due to BPH. Prostiva is a registered trademark of Medtronic, Inc., used under license. All other trademarks are the property of Urologix. Additional info from OTC: |
No news found.